Ligand validation:8A74

GPP: GERANYL DIPHOSPHATE

GPP is a Ligand Of Interest in 8A74 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8A74_GPP_A_505	57%	71%	0.16	0.937	0.49	0.62	-	-	0	0	100%	1
8A74_GPP_B_505	26%	71%	0.226	0.865	0.5	0.63	-	-	7	0	100%	0.7
8A78_GPP_A_505	95%	67%	0.069	0.971	0.58	0.7	-	-	1	0	100%	1
8A73_GPP_A_505	93%	67%	0.075	0.971	0.56	0.71	-	-	0	0	100%	1
8A70_GPP_A_505	85%	72%	0.1	0.965	0.49	0.6	-	-	0	0	100%	1
8A7U_GPP_A_506	79%	56%	0.113	0.96	0.79	0.91	-	1	0	0	100%	1
8A7R_GPP_A_505	71%	73%	0.115	0.936	0.52	0.53	-	-	0	0	100%	1
2VG3_GPP_B_1298	100%	7%	0.05	0.994	2.78	2.12	3	5	0	0	100%	1
4K7T_GPP_A_101	97%	51%	0.069	0.985	0.87	1.02	1	-	0	0	100%	1
6PGN_GPP_A_402	91%	55%	0.085	0.973	0.68	1.04	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.